FDA Removes Pacira Warning Letter in Midst of Free Speech Suit
We have previously written about Pacira Pharmaceuticals, Inc. and their constitutional challenge against the Food and Drug…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Monthly Archives
October 2015
Open Payments: Research Payments Distorted by Including Value of the…
The Open Payments program, an element of the Affordable Care Act (the "Sunshine Act"), has required the healthcare…
Orthopaedic Board May Use Surgeon Scorecard in Certification Process
ProPublica has recently announced that the American Board of Orthopaedic Surgery, the board responsible for certifying orthopedic…
FDA Establishes the Patient Engagement Advisory Committee
There has been a surge in the development of new medical technologies over the last couple of decades. When looking at the way…
Senator Klobuchar Calls on FTC To Investigate Pharma Companies for…
Last week, U.S. Senator Amy Klobuchar (D-MN) called on the Federal Trade Commission (FTC) to investigate pharmaceutical…
PharMerica to pay $9.25M in Dept. of Justice settlement
The Louisville, Kentucky-based PharMerica, the nation's second-largest nursing home pharmacy, agreed on October 7 to pay…
FDA Notice of PDUFA Reauthorization – Public Comments due April 29, 2016
The Food and Drug Administration has issued a notice that they are reopening the comment period for interested parties to submit…
District Court Grants Permanent Injunction Against Device Maker
On Wednesday October 7, a federal judge in South Dakota granted the Food and Drug Administration (FDA) a permanent injunction…
Open Payments Analytics Webinar
This Thursday, October 15, 2015, at 2:00 pm EST, Streebo will be presenting a webinar on “Strategies to Improve Compliance…
Life Science Compliance Update: October Issue Covers Shifting Enforcement…
The latest issue is of Life Science Compliance Update is available for download. The October issue features articles on…